La FDA aprobó el primer tratamiento para la sordera genética
El organismo regulador de alimentos y medicamentos de Estados Unidos aprobó una terapia que sustituye la ausencia de la proteína otoferlina (OTOF) en pacientes con hipoacusia congénita y posibilita mejorar la percepción de sonidos
ORIGINAL SOURCE →via Infobae
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · conflict
- [CONFLICT] Intermodal Asia
- [CONFLICT] AKBANK EMEKLİ BANKA PROMOSYON TUTARI NİSAN 2026: Akbank emeklilere ne kadar promosyon ödüyor?
- [CONFLICT] MİT Akademi'den "yapay zeka" uyarıları
- [CONFLICT] American flags raised in Metula to protest US influence amid anger over ceasefire extension
- [CONFLICT] Devlet hastanesinde rüşvet davası
- [CONFLICT] Mendoza: Have 'huge responsibility' with Raiders